Fundraising Fox
Augmedix
AcquiredSan Francisco, US · Founded 2018 · 377 employees on LinkedIn · 11 known investors
Find your way into Augmedix
Sign up to see every warm intro you have to Augmedix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Augmedix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Augmedix builds AI-driven documentation technology for clinicians, aiming to reduce time spent on technology so providers can focus on patient care. It serves healthcare organizations and their clinical staff.
Also known as Augmedix
Founders & leadership
Augmedix was founded in 2018 by Ian Shakil and Pelu Tran.
Board
Investors · 11
How we know: board seat on SEC Form D · funding news · Not right? Tell us
How we know: Evolution VC Partners's portfolio page · Not right? Tell us
__Twitter.png)
How we know: Great Oaks Venture Capital's portfolio page · Not right? Tell us
How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us
How we know: OVO Fund's portfolio page · Not right? Tell us
How we know: StartX's portfolio page · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: funding news · techcrunch.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$67.9M disclosed across 3 of 5 rounds · 2014–2026
- Undisclosed amountSeries CMar 2026Source ↗
▶$12MraisedMay 2023 · 2 investors · Other Health CareRule 506(b)
- Laurie A. S. McGrawDirector
- Ian ShakilDirector
- Joseph MarksDirector
- William J. FebboDirector
- Jason KrikorianDirector
- Margie TraylorDirector
- Robert FaulknerDirector
- Roderick O'ReillyDirector
- Emmanuel KrakarisExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$25.9MraisedOct 2020 · 36 investors · Other Health CareRule 506(b)
- Emmanuel KrakarisExecutive Officer, Director
- Ian ShakilExecutive Officer, Director
- Paul GinocchioExecutive Officer
- Sandra BreberExecutive Officer
- Joseph MarksDirector
- Gerard van Hamel PlaterinkDirector
- Jason KrikorianDirector
- Jennifer M. CarterDirector
- Jonathan HawkinsExecutive Officer
- Offering amount
- $25.9M
- Amount sold
- $25.9M
- Sales commissions
- $2.5M
- Placement agents
- B. Riley Securities, Inc., GP Nurmenkari Inc., Stifel, Nicolaus & Company, Incorporated
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$29.9MraisedOct 2020 · 61 investors · Other Health CareRule 506(b)
- Emmanuel KrakarisExecutive Officer, Director
- Ian ShakilExecutive Officer, Director
- Sandra BreberExecutive Officer
- Joseph MarksDirector
- Gerard van Hamel PlaterinkDirector
- Jason KrikorianDirector
- Jennifer M. CarterDirector
- Jonathan HawkinsExecutive Officer
- Offering amount
- $29.9M
- Amount sold
- $29.9M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Augmedix provides ambient artificial intelligence documentation technology for clinicians. Its systems capture the conversation that takes place in the exam room and generate medical notes intended to be accurate, complete and readable, handling electronic health record (EHR) documentation so that clinicians can remain engaged with patients during visits. The company offers a range of products spanning care settings from the emergency department to primary care.
The product line combines automated AI with optional human support, described by the company as spanning self-service to full-service configurations, so that organizations can select the level of automation appropriate to their clinicians. Augmedix offers a dedicated application for emergency medicine and states its AI is fine-tuned for oncology and other specialties, addressing complex clinical workflows and noisy point-of-care environments. The platform integrates with widely used EHR systems, and the company cites HITRUST certification and HIPAA compliance as the basis of its enterprise security posture.
Business model
Augmedix sells documentation products to healthcare enterprises and individual clinicians, offering a product suite with varying levels of AI automation and human support so buyers can choose according to need and budget, ranging from self-service to full-service options.
Traction
Augmedix reports approximately 10 million notes generated in the decade following its 2013 launch of ambient medical documentation, and cites use by healthcare organizations including Alabama Oncology, Paradise Medical Group and Dignity Health Medical Group.
▸Full profile — market position, technology, go-to-market, history
Market position
Augmedix describes itself as the first provider of ambient medical documentation to health systems, hospitals and clinics, beginning in 2013, and says it is used by leading healthcare organizations. It was named in an August 2024 listing of artificial intelligence companies in healthcare to watch.
Augmedix positions itself as the only vendor offering a suite of documentation solutions with customizable levels of AI automation and human support, alongside specialty-specific capabilities such as a dedicated emergency medicine application and AI tuned for oncology, plus HITRUST certification and HIPAA compliance.
Technology
Ambient AI captures exam-room conversation and generates medical notes, with models fine-tuned for specialties such as oncology, a purpose-built emergency medicine application, integrations with popular EHR systems, and security controls evidenced by HITRUST certification and HIPAA compliance.
Go-to-market
The company markets directly to healthcare organizations and clinicians through its website, with demo requests handled by its sales team, and supports prospects via webinars and media coverage. Inbound inquiry channels include hospitals and health systems, independent physicians and physician group practices.
Hospitals and health systems, physician group practices and independent physicians across settings including emergency medicine, primary care and oncology; testimonials cite clinicians at Alabama Oncology, Paradise Medical Group and Dignity Health Medical Group.
History
Augmedix states that in 2013 it became the first company to deliver ambient medical documentation to health systems, hospitals and clinics, and that roughly a decade later it had produced 10 million notes. On October 2, 2024, the company announced that Commure had completed its merger with Augmedix.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
4 people who came through Augmedix went on to found or lead other companies.
Timeline · 1
launches, deals, and filingsAugmedix announced that Commure completed its merger with Augmedix.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 1
primary sources listed
- Augmedix Exits falseaugmedix.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Augmedix do?
- Augmedix provides ambient AI documentation that captures clinical visits and generates EHR-ready medical notes for clinicians.
- Who founded Augmedix?
- Augmedix was founded by Ian Shakil, Pelu Tran in 2018.
- Who are Augmedix's investors?
- Augmedix's investors include DCM Ventures, Evolution VC Partners, Gaingels, Great Oaks Venture Capital, LifeSci Venture Partners, OVO Fund, Sand Hill Angels, StartX and 3 more.
- How much funding has Augmedix raised?
- Augmedix has disclosed $67.9M raised across 3 of its 5 known rounds.
- Where is Augmedix headquartered?
- Augmedix is headquartered in San Francisco, US.